» Articles » PMID: 32190942

One-year Outcomes for Da Vinci Single Port Robot for Transoral Robotic Surgery

Overview
Journal Head Neck
Date 2020 Mar 20
PMID 32190942
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The da Vinci single-port (SP) robot is a new instrument for transoral robotic surgery (TORS) in oropharyngeal cancers (OPSCCs). We describe one-year SP surgical outcomes and compare them to da Vinci Si outcomes.

Methods: Retrospective cohort study at a high-volume TORS center. Consecutive patients undergoing TORS SP procedures from 10/2018 to 09/2019 were included. SP OPSCC outcomes were compared to a historical cohort of Si OPSCC patients. t tests were used to compare continuous variables; χ or Wilcoxon rank-sum tests were used to compare nonparametric categorical variables.

Results: Seventy-eight patients underwent SP TORS. The bleed rate was 5.1%, mortality rate was 2.6%, and conversion rate was 0%. Compared to the Si cohort, OPSCC patients undergoing TORS SP procedures saw no significant differences in operative time or post-TORS bleeds (P > .05).

Conclusions: The SP is a comparably safe surgical instrument. Overall learning curve for the SP was rapid among experienced TORS surgeons.

Citing Articles

Subcostal uniportal robotic anatomic lung resection: A pilot trial.

Cheng C, Tagkalos E, Ng C, Hsu Y, Huang Y, Wu C JTCVS Tech. 2024; 25:160-169.

PMID: 38899114 PMC: 11184444. DOI: 10.1016/j.xjtc.2024.01.024.


Role of TORS as De-Escalation Strategy in HPV-Related Oropharyngeal Cancer, What We Need to Know.

Molteni G, Bassani S, Arsie A, Zampieri E, Mannelli G, Orlandi E Healthcare (Basel). 2024; 12(10).

PMID: 38786424 PMC: 11121063. DOI: 10.3390/healthcare12101014.


Soft tissue surgical robot for minimally invasive surgery: a review.

Kim M, Zhang Y, Jin S Biomed Eng Lett. 2023; 13(4):561-569.

PMID: 37872994 PMC: 10590359. DOI: 10.1007/s13534-023-00326-3.


Single-port multiport robotic total mesorectal excision for rectal cancer: initial experiences by case-matched analysis of short-term outcomes.

Jeong M, Kim H, Choi G, Song S, Park J, Park S Ann Surg Treat Res. 2023; 105(2):99-106.

PMID: 37564948 PMC: 10409629. DOI: 10.4174/astr.2023.105.2.99.


Editorial: Considerations in the surgical management of HPV-positive oropharyngeal squamous cell carcinoma.

Mallen-St Clair J, Orosco R Front Oncol. 2023; 13:1205525.

PMID: 37384295 PMC: 10296762. DOI: 10.3389/fonc.2023.1205525.